Last reviewed · How we verify

NCT05876169

How Does Orthognathic Surgery Affect Jaw and Neck Motor Function?

ENROLLING BY INVITATION NA Last updated 25 May 2023
What this trial tests

NA trial testing Orthognathic surgery in Cleft Lip and Palate in 40 participants. Enrolling by invitation.

Timeline
6 September 2022
Primary endpoint
12 December 2026
12 December 2026

Quick facts

Lead sponsorUmeå University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date6 September 2022
Primary completion12 December 2026
Estimated completion12 December 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Umeå University

Who can join

Adults 16 to 50, any sex, with Cleft Lip and Palate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a prospective longitudinal study design, details in jaw-neck kinematics and electromyography (EMG) activity changes in patients (women and men) referred for surgical correction of basal relations between the maxilla and mandible over time; pre-operative and during follow-up 8 weeks and 18 months after surgical correction will be evaluated. The results will contribute with novel insights on jaw-neck motor function before, in short- and long-term after the surgical process. We will have blinded evaluation of outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Orthognathic surgery

Trials testing the same drug.

Other recruiting trials for Cleft Lip and Palate

Currently open trials in the same condition.

Other Umeå University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05876169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing